• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Trimodality therapy in variant urothelial carcinoma: choose wisely.变异型尿路上皮癌的三联疗法：明智选择。
Transl Androl Urol. 2017 Apr;6(2):322-325. doi: 10.21037/tau.2017.03.59.
2
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.经三联膀胱保留疗法治疗的尿路上皮癌组织学变异型患者的临床结局。
Eur Urol. 2017 Jul;72(1):54-60. doi: 10.1016/j.eururo.2016.12.002. Epub 2016 Dec 28.
3
Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.膀胱癌保留膀胱的三联疗法治疗肌层浸润性膀胱癌。
Curr Oncol Rep. 2018 Jun 30;20(9):66. doi: 10.1007/s11912-018-0711-0.
4
Lipid-Rich Variant of Urothelial Carcinoma Presenting as the Dominant Morphology in a Recurrent Tumor After Local Therapy.在局部治疗后的复发性肿瘤中以主要形态出现的富含脂质的尿路上皮癌变体
Am J Case Rep. 2018 Apr 23;19:478-481. doi: 10.12659/ajcr.908317.
5
The use of trimodality therapy for the treatment of operable esophageal carcinoma in the veteran population: patient survival and outcome analysis.三联疗法用于治疗退伍军人中可手术食管癌的疗效：患者生存率及预后分析
Cancer. 2001 Sep 1;92(5):1272-80. doi: 10.1002/1097-0142(20010901)92:5<1272::aid-cncr1448>3.0.co;2-a.
6
PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall.巢式尿路上皮癌中 PAX8 的阳性表达：一个潜在的诊断陷阱。
Hum Pathol. 2019 Dec;94:11-15. doi: 10.1016/j.humpath.2019.09.012. Epub 2019 Oct 25.
7
Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.模仿尿路上皮癌的Florid von Brunn巢：与尿路上皮癌巢状变体的形态学和免疫组化比较
Am J Surg Pathol. 2003 Sep;27(9):1243-52. doi: 10.1097/00000478-200309000-00008.
8
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.组织学亚型对上尿路尿路上皮癌患者临床结局的影响。
J Urol. 2012 Aug;188(2):398-404. doi: 10.1016/j.juro.2012.04.009. Epub 2012 Jun 13.
9
Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.巢式尿路上皮癌行根治性膀胱切除术的结局：匹配队列分析。
J Urol. 2013 May;189(5):1670-5. doi: 10.1016/j.juro.2012.11.006. Epub 2012 Nov 6.
10
[MICROCYSTIC VARIANT OF UROTHELIAL CARCINOMA IN URINARY BLADDER: A CASE REPORT].[膀胱尿路上皮癌微囊性变异型：一例报告]
Nihon Hinyokika Gakkai Zasshi. 2017;108(2):101-105. doi: 10.5980/jpnjurol.108.101.

引用本文的文献

1
Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking.橙皮素通过网络药理学和分子对接促进膀胱癌细胞死亡的 PI3K/AKT 通路。
Sci Rep. 2024 Jan 10;14(1):1009. doi: 10.1038/s41598-023-50476-8.
2
The Green Anti-Cancer Weapon. The Role of Natural Compounds in Bladder Cancer Treatment.绿色抗癌武器：天然化合物在膀胱癌治疗中的作用。
Int J Mol Sci. 2021 Jul 21;22(15):7787. doi: 10.3390/ijms22157787.

本文引用的文献

1
Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.单纯而非混合组织学变体与膀胱癌患者根治性膀胱切除术后的不良生存相关。
Clin Genitourin Cancer. 2017 Aug;15(4):e603-e607. doi: 10.1016/j.clgc.2016.12.006. Epub 2016 Dec 14.
2
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.经三联膀胱保留疗法治疗的尿路上皮癌组织学变异型患者的临床结局。
Eur Urol. 2017 Jul;72(1):54-60. doi: 10.1016/j.eururo.2016.12.002. Epub 2016 Dec 28.
3
Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy.微乳头形态是经尿道切除术和放化疗治疗的尿路上皮癌患者预后不良的一个指标。
Virchows Arch. 2016 Sep;469(3):339-44. doi: 10.1007/s00428-016-1986-x. Epub 2016 Jul 8.
4
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.2016 年更新版 EAU 肌层浸润性和转移性膀胱癌临床实践指南。
Eur Urol. 2017 Mar;71(3):462-475. doi: 10.1016/j.eururo.2016.06.020. Epub 2016 Jun 30.
5
Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.肌层浸润性和转移性膀胱癌指南（欧洲泌尿外科学会指南）：美国临床肿瘤学会临床实践指南认可。
J Clin Oncol. 2016 Jun 1;34(16):1945-52. doi: 10.1200/JCO.2015.65.9797. Epub 2016 Mar 21.
6
Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.肌层浸润性膀胱癌新辅助化疗完全病理缓解（pT0）的预测因素
Clin Genitourin Cancer. 2016 Feb;14(1):e59-65. doi: 10.1016/j.clgc.2015.09.013. Epub 2015 Oct 3.
7
Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.膀胱尿路上皮癌伴鳞状或腺性分化患者新辅助化疗及根治性膀胱切除术后的临床结局
Clin Genitourin Cancer. 2016 Feb;14(1):82-8. doi: 10.1016/j.clgc.2015.08.006. Epub 2015 Aug 29.
8
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer.初治尿路上皮癌分子分类中的预后基因表达特征可预测新辅助化疗的临床结局：一项尿路上皮癌剂量密集型甲氨蝶呤、长春碱、阿霉素和顺铂联合贝伐单抗的2期试验
Eur Urol. 2016 May;69(5):855-62. doi: 10.1016/j.eururo.2015.08.034. Epub 2015 Sep 3.
9
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.根治性膀胱切除术与肌肉浸润性膀胱癌的保留器官三联疗法：一项临床试验的系统评价
Crit Rev Oncol Hematol. 2015 Sep;95(3):387-96. doi: 10.1016/j.critrevonc.2015.04.006. Epub 2015 Apr 17.
10
Nonurothelial bladder cancer and rare variant histologies.非尿路上皮膀胱癌及罕见变异组织学类型
Hematol Oncol Clin North Am. 2015 Apr;29(2):237-52, viii. doi: 10.1016/j.hoc.2014.10.011. Epub 2015 Jan 9.

Trimodality therapy in variant urothelial carcinoma: choose wisely.

作者信息

Vlachostergios Panagiotis J, Jakubowski Christopher, Tagawa Scott T

机构信息

Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

出版信息

Transl Androl Urol. 2017 Apr;6(2):322-325. doi: 10.21037/tau.2017.03.59.

DOI:10.21037/tau.2017.03.59
PMID:28540247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5422701/
Abstract
摘要